Sector revisions Perspective Therapeutics, Inc.

Stocks

Market Closed - NYSE 01:30:00 05/09/2026 am IST			5-day change	1st Jan Change
3.130 ^USD	+0.32%		+0.64%	+13.82%

19/08	BMO Capital Initiates Perspective Therapeutics at Outperform	MT
14/08	BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	Nbr of analysts
PERSPECTIVE THERAPEUTICS, INC.		14
LONZA GROUP AG		23
REVOLUTION MEDICINES, INC.		20
IQVIA HOLDINGS INC.		18
BEONE MEDICINES AG		28
CELLTRION, INC.		22
ASCENDIS PHARMA A/S	-	20
MEDPACE HOLDINGS, INC.		12
EUROFINS SCIENTIFIC SE		14
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		14
ICON PUBLIC LIMITED COMPANY		16
TEMPUS AI, INC.		15
BIO-TECHNE CORPORATION		11
ABIVAX		6
PHARMARON BEIJING CO., LTD.		11
PRAXIS PRECISION MEDICINES, INC.		19
KYMERA THERAPEUTICS, INC.		21
IONIS PHARMACEUTICALS, INC.		22
PROTAGONIST THERAPEUTICS, INC.		13
QIAGEN N.V.		14
Average		17
Weighted average by Cap.		19

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!